UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date: December 21, 2018
Accession Number: 0001193125-18-348302
Submission Type: POS AM
CIK: 0001114220
Company Name: KERYX BIOPHARMACEUTICALS INC
File Number: 333-133051
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Keryx Biopharmaceuticals, Inc. (delisted) Charts.
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Keryx Biopharmaceuticals, Inc. (delisted) Charts.